Clinical trial NCT03856437: A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination
Official title: A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Cervical Cancer
Anal Cancer
Penile Cancer
Lead sponsor: University of Maryland, College Park
Sponsor class: OTHER
Collaborators: name: National Cancer Institute (NCI)
First posted: 2019-02-27
Enrollment: 1170
Sex: ALL
Minimum age (years): 18
Maximum age (years): 99
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: PREVENTION

Brief summary: The goal of this study is to determine the effects of message framing (gain vs. loss) on African American parents' acceptance of the HPV vaccine and how such effects are moderated by parents' salient beliefs prior to message exposure. Participants are randomized into gain and loss conditions in which they view either gain-framed or loss-framed HPV vaccination messages. Key outcome variables include parents' attitudes and intentions toward vaccinating their children against HPV.

Detailed description: The goal of this study is to determine the effects of message framing (gain vs. loss) on African American parents' acceptance of the HPV vaccine and how such effects are moderated by parents' salient beliefs prior to message exposure. Participants recruited from local communities and online panels will complete a computer-assisted survey. In the survey participants will first answer questions related to their beliefs about HPV and the HPV vaccine (e.g., perceived susceptibility, perceived severity, perceived efficacy, perceived safety, etc.), as well as other background information. Then they will be presented with either a gain-framed or loss-framed human papillomavirus vaccination message. After the message exposure, they will answer questions related to their attitudes toward HPV vaccination, intentions to vaccinate their children, as well as other message response measures. Eligible participants are at least 21 years old, self-identify as African American, and are custodial parents or caretakers of at least one child ages 9-17 who has not initiated the HPV vaccine series.

Eligibility criteria: Inclusion Criteria:

* 18 years or older
* Self-identify as African American
* Custodial parent or caretaker of at least one child under the age of 18 who has not been fully vaccinated against HPV.
* Has access to Internet to complete the study

Exclusion Criteria:

* Younger than 18 years
* Does not self-identify as African American
* Not a custodial parent or caretaker of at least one child under the age of 18 who has not been fully vaccinated against HPV.
* Has no access to Internet to complete the study

Primary outcomes:
measure: Attitudes
timeFrame: baseline posttest (test was approximately 5 minutes to complete)
measure: Intention to Vaccinate Free of Cost
timeFrame: baseline posttest (test was approximately 5 minutes to complete)
Secondary outcomes:
measure: Intention to Vaccinate With Cost
timeFrame: baseline posttest (test was approximately 5 minutes to complete)
Other outcomes:
Locations:
city: College Park
country: United States
facility: University of Maryland
state: Maryland
Study officials:
affiliation: University of Maryland, College Park
name: Xiaoli Nan
role: PRINCIPAL_INVESTIGATOR
References: